Trybala E, Liljeqvist J, Svennerholm B, Bergstrom T
J Virol. 2000; 74(19):9106-14.
PMID: 10982357
PMC: 102109.
DOI: 10.1128/jvi.74.19.9106-9114.2000.
Ikeda K, Wakimoto H, Ichikawa T, Jhung S, Hochberg F, Louis D
J Virol. 2000; 74(10):4765-75.
PMID: 10775615
PMC: 111999.
DOI: 10.1128/jvi.74.10.4765-4775.2000.
Montefiori D
Springer Semin Immunopathol. 1997; 18(3):371-90.
PMID: 9089955
DOI: 10.1007/BF00813504.
Dyer A, Banfield B, Martindale D, Spannier D, Tufaro F
J Virol. 1997; 71(1):191-8.
PMID: 8985338
PMC: 191039.
DOI: 10.1128/JVI.71.1.191-198.1997.
Friedman H, Wang L, Fishman N, Lambris J, Eisenberg R, Cohen G
J Virol. 1996; 70(7):4253-60.
PMID: 8676446
PMC: 190356.
DOI: 10.1128/JVI.70.7.4253-4260.1996.
A block in glycoprotein processing correlates with small plaque morphology and virion targetting to cell-cell junctions for an oral and an anal strain of herpes simplex virus type-1.
Dick J, Rosenthal K
Arch Virol. 1995; 140(12):2163-81.
PMID: 8572939
DOI: 10.1007/BF01323238.
Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice.
Ghiasi H, Kaiwar R, Nesburn A, Slanina S, Wechsler S
J Virol. 1994; 68(4):2118-26.
PMID: 8138996
PMC: 236686.
DOI: 10.1128/JVI.68.4.2118-2126.1994.
Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160.
Benjouad A, Gluckman J, Montagnier L, Bahraoui E
J Virol. 1993; 67(3):1693-7.
PMID: 7679751
PMC: 237545.
DOI: 10.1128/JVI.67.3.1693-1697.1993.
Inhibitors of protein glycosylation and glycoprotein processing in viral systems.
Datema R, Olofsson S, Romero P
Pharmacol Ther. 1987; 33(2-3):221-86.
PMID: 3310033
PMC: 7125576.
DOI: 10.1016/0163-7258(87)90066-0.
Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates.
Friedman H, Glorioso J, Cohen G, Hastings J, Harris S, Eisenberg R
J Virol. 1986; 60(2):470-5.
PMID: 3021981
PMC: 288914.
DOI: 10.1128/JVI.60.2.470-475.1986.
C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2.
Ponce de Leon M, Friedman H, Fries L, Frank M, Cohen G, Eisenberg R
J Virol. 1988; 62(11):4027-36.
PMID: 2845122
PMC: 253832.
DOI: 10.1128/JVI.62.11.4027-4036.1988.
Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity.
McNearney T, ODell C, Holers V, Spear P, Atkinson J
J Exp Med. 1987; 166(5):1525-35.
PMID: 2824652
PMC: 2189652.
DOI: 10.1084/jem.166.5.1525.
Use of a glucocorticoid-inducible promoter for expression of herpes simplex virus type 1 glycoprotein gC1, a cytotoxic protein in mammalian cells.
Friedman H, Yee A, DIGGELMANN H, Hastings J, Tal-Singer R, Eisenberg R
Mol Cell Biol. 1989; 9(6):2303-14.
PMID: 2548078
PMC: 362303.
DOI: 10.1128/mcb.9.6.2303-2314.1989.
Escherichia coli-derived envelope protein gD but not gC antigens of herpes simplex virus protect mice against a lethal challenge with HSV-1 and HSV-2.
Broker M, Abel K, Kohler R, Hilfenhaus J, Amann E
Med Microbiol Immunol. 1990; 179(3):145-59.
PMID: 2169577
DOI: 10.1007/BF00202392.
Structural basis of C3b binding by glycoprotein C of herpes simplex virus.
HUNG S, Srinivasan S, Friedman H, Eisenberg R, Cohen G
J Virol. 1992; 66(7):4013-27.
PMID: 1602532
PMC: 241204.
DOI: 10.1128/JVI.66.7.4013-4027.1992.
Factors influencing the interaction of herpes simplex virus glycoprotein C with the third component of complement.
Huemer H, Larcher C, Dierich M, Falke D
Arch Virol. 1992; 127(1-4):291-303.
PMID: 1333754
DOI: 10.1007/BF01309591.